Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase

Infection and Immunity

Volumn 67, Issue 4, 1999, Pages 1828-1836

  Aratani, Yasuaki ^a,b   Koyama, Hideki ^a   Nyui, Sei Ichiro ^a   Suzuki, Kazuo ^c   Kura, Fumiaki ^c   Maeda, Nobuyo ^b  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ARTICLE; CANDIDIASIS; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE TARGETING; GENE THERAPY; HOST SUSCEPTIBILITY; IMMUNE DEFICIENCY; IMMUNOREGULATION; INFECTION SENSITIVITY; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0033041907     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.4.1828-1836.1999     Document Type: Article

References (55)

1. Andrews, P. C., and N. I. Krinsky. 1981. The reductive cleavage of myeloperoxidase in half, producing enzymically active hemi-myeloperoxidase. J. Biol. Chem. 256:4211-4218.
2. Badwey, J. A., and M. L. Karnovsky. 1980. Active oxygen species and the functions of phagocytic leukocytes. Annu. Rev. Biochem. 49:695-726.
3. Bainton, D. F., J. L. Ullyot, and M. G. Farquhar. 1971. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J. Exp. Med. 134:907-934.
4. Belaaouaj, A., R. McCarthy, M. Baumann, Z. Gao, T. J. Ley, S. N. Abraham, and S. D. Shapiro. 1998. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat. Med. 4:615-618.
5. Bradley, P. P., R. D. Christensen, and G. Rothstein. 1982. Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 60:618-622.
6. Cech, P., H. Stalder, J. J. Widmann, A. Rohner, and P. A. Miescher. 1979. Leukocyte myeloperoxidase deficiency and diabetes mellitus associated with Candida albicans liver abscess. Am. J. Med. 66:149-153.
7. Clark, R. A., and S. Szot. 1981. The myeloperoxidase-hydrogen peroxidehalide system as effector of neutrophil-mediated tumor cell cytotoxicity. J. Immunol. 126:1295-1301.
8. Cramer, R., M. R. Soranzo, P. Dri, G. D. Rottini, M. Bramezza, S. Cirielli, and P. Patriarca. 1982. Incidence of myeloperoxidase deficiency in an area of northern Italy: histochemical, biochemical and functional studies. Br. J. Hematol. 51:81-87.
9. Diamond, R. D., R. A. Clark, and C. C. Haudenschild. 1980. Damage to Candida albicans hyphae and pseudohyphae by the myeloperoxidase system and oxidative products of neutrophil metabolism in vitro. J. Clin. Investig. 66:908-917.
10. Domigan, N. M., T. S. Charlton, M. W. Duncan, C. C. Winterbourn, and A. J. Kettle. 1995. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J. Biol. Chem. 270:16542-16548.
11. Eiserich, J. P., C. E. Cross, A. D. Jones, B. Halliwell, and A. Vliet. 1996. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. J. Biol. Chem. 271:19199-19208.
12. Eiserich, J. P., M. Hristova, C. E. Cross, A. D. Jones, B. A. Freeman, B. Halliwell, and A. Vliet. 1998. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391:393-397.
13. Ferrante, A. 1989. Tumor necrosis factor alpha potentiates neutrophil anti-microbial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect. Immun. 57:2115-2122.
14. Fridovich, I. 1985. Cytochrome c, p. 121-122. In R. A. Greenwald (ed.), Handbook of methods for oxygen radical research. CRC Press, Inc., Boca Raton, Fla.
15. Fulurija, A., R. B. Ashman, and J. M. Papadimitriou. 1996. Neutrophil depletion increases susceptibility to systemic and vaginal candidiasis in mice, and reveals differences between brain and kidney in mechanisms of host resistance. Microbiology 142:3487-3496.
16. Hager, L. P., D. R. Morris, F. S. Brown, and H. Eberwein. 1966. Chloroperoxidase. J. Biol. Chem. 241:1769-1777.
17. Hashinaka, K., C. Nishio, S.-J. Hur, F. Sakiyama, S. Tsunasawa, and M. Yamada. 1988. Multiple species of myeloperoxidase messenger RNAs produced by alternative splicing and differential polyadenylation. Biochemistry 27:5906-5914.
18. Hazen, S. L., and J. W. Heinecke. 1997. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Investig. 99:2075-2081.
19. Johnson, K., I. Gemperlein, S. Hudson, S. Shane, and G. Rovera. 1989. Complete nucleotide sequence of the human myeloperoxidase gene. Nucleic Acids Res. 17:7985-7986.
20. Káposzta, R., P. Tree, L. Maródi, and S. Gordon. 1998. Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect. Immun. 66:1708-1717.
21. Kettle, A. J., and C. C. Winterbourn. 1990. Superoxide enhances hypochlorous acid production by stimulated human neutrophils. Biochim. Biophys. Acta 1052:379-385.
22. Kitahara, M., H. J. Eyre, Y. Simonian, C. L. Atkin, and S. J. Hasstedt. 1981. Hereditary myeloperoxidase deficiency. Blood 57:888-893.
23. Klebanoff, S. J. 1991. Myeloperoxidase: occurrence and biological function, p. 1-35. In E. Johannes, E. E. Kathleen, and B. G. Mathaw (ed.), Peroxidase in chemistry and biology. CRC Press, Inc., Boca Raton, Fla.
24. Klebanoff, S. J., and R. W. Coombs. 1992. Viricidal effect of polymorphonuclear leukocytes on human immunodeficiency virus-1. Role of the myeloperoxidase system. J. Clin. Investig. 89:2014-2017.
25. Koller, B. H., L. J. Hagemann, T. Doetschman, J. R. Hagaman, S. Huang, P. J. Williams, N. L. First, N. Maeda, and O. Smithies. 1989. Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells. Proc. Natl. Acad. Sci. USA 86:8927-8931.
26. Lal, S., M. Mitsuyama, M. Miyata, N. Ogata, K. Amako, and K. Nomoto. 1986. Pulmonary defence mechanism in mice. A comparative role of alveolar macrophages and polymorphonuclear cells against infection with Candida albicans. J. Clin. Lab. Immunol. 19:127-133.
27. Lefokowitz, D. L., K. Mills, D. Morgan, and S. S. Lefokowitz. 1992. Macrophage activation and immunomodulation by myeloperoxidase. Proc. Soc. Exp. Biol. Med. 199:204-210.
28. Lefokowitz, S. S., M. P. Gelderman, D. L. Lefokowitz, N. Moguilevsky, and A. Bollen. 1996. Phagocytosis and intracellular killing of Candida albicans by macrophages exposed to myeloperoxidase. J. Infect. Dis. 173:1202-1207.
29. Lehrer, R. I., and M. J. Cline. 1969. Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J. Clin. Investig. 48:1478-1488.
30. Lincoln, J. A., D. L. Lefokowitz, T. Cain, A. Castro, K. C. Mills, S. S. Lefokowitz, N. Moguilevsky, and A. Bollen. 1995. Exogenous myeloperoxidase enhances bacterial phagocytosis and intracellular killing by macrophages. Infect. Immun. 63:3042-3047.
31. London, S. J., T. A. Lehman, and J. A. Taylor. 1997. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res. 57:5001-5003.
32. Mansour, S. L., K. R. Thomas, and M. R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336:348-352.
33. Maródi, L., C. Tournay, R. Káposzta, R. B. Johnston, and N. Moguilevsky, 1998. Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor. Infect. Immun. 66:2750-2754.
34. Nauseef, W. M., M. Cogley, S. Bock, and P. E. Petrides. 1998. Pattern of inheritance in hereditary myeloperoxidase deficiency associated with the R569W missense mutation. J. Leukocyte Biol. 63:264-269.
35. Nguyen, C., and H. P. Katner. 1997. Myeloperoxidase deficiency manifesting as pustular Candida dermatitis. Clin. Infect. Dis. 24:258-260.
36. Olsen, R. L., and C. Little. 1984. Studies of the subunits of human myeloperoxidase. Biochem. J. 222:701-709.
37. Parry, M. F., R. K. Root, J. A. Metcalf, K. K. Delaney, L. S. Kaplow, and W. J. Richar. 1981. Myeloperoxidase deficiency. Ann. Intern. Med. 95:293-301.
38. Pollock, J. D., D. A. Williams, M. A. C. Gifford, L. L. Li, X. Du, J. Fisherman, S. H. Orkin, C. M. Doerschuk, and M. C. Dinauer. 1995 Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9:202-209.
39. Robinson, T. J., D. L. Morris, and D. H. Ledbetter. 1990. Chromosomal assignment and regional localization of myeloperoxidase in the mouse. Cytogenet. Cell Genet. 53:83-86.
40. Romano, M., P. Dri, L. Dadalt, P. Patriarca, and F. E. Baralle. 1997. Biochemical and molecular characterization of hereditary myeloperoxidase deficiency. Blood 90:4126-4134.
41. Rosen, H., and S. J. Klebanoff. 1976. Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes. J. Clin. Investig. 58:50-60.
42. Sawyer, R. T. 1990. Experimental pulmonary candidiasis. Mycopathologia 109:99-109.
43. Stendahl, O., B.-I. Coble, C. Dahlgen, J. Hed, and L. Molin. 1984. Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient. J. Clin. Investig. 73:366-373.
44. Sullivan, P. M., H. Mezdour, V. Aratani, C. Knouff, J. Najib, R. L. Reddick, S. H. Quarfordt, and N. Maeda. 1997. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272: 17972-17980.
45. Suzuki, K., H. Ota, S. Sasagawa, T. Sakatani, and T. Fujikura. 1983. Assay method for myeloperoxidase in human polymorphonuclear leukocytes. Anal. Biochem. 132:345-352.
46. Venturelli, D., S. Bittenbender, and G. Rovera. 1989. Sequence of the murine myeloperoxidase (MPO) gene. Nucleic Acids Res. 17:7987-7988.
47. Watanabe, M., J. Osada, Y. Aratani, K. Kluckman, R. Reddick, M. R. Malinow, and N. Maeda. 1995. Mice deficient in cystathionine β-synthase: animal models for mild and severe homocyst(e)inemia. Proc. Natl. Acad. Sci. USA 92:1585-1589.
48. Weinberg, D. S., and E. R. Unanue. 1981. Antigen-presenting function of alveolar macrophages: uptake and presentation of Listeria monocytogenes. J. Immunol. 126:794-799.
49. Wright, C. D., J. U. Bowie, G. R. Gray, and R. D. Nelson. 1983. Candidacidal activity of myeloperoxidase: mechanisms of inhibitory influence of soluble cell wall mannan. Infect. Immun. 42:76-80.
50. Wright, C. D., and R. D. Nelson. 1985. Candidacidal activity of myeloperoxidase: therapeutic influence of the enzyme in vivo. Infect. Immun. 47:363-365.
51. Yamada, M., S. J. Hur, K. Hashinaka, K. Tsuneoka, T. Saeki, C. Nishio, F. Sakiyama, and S. Tsunasawa. 1987. Isolation and characterization of a cDNA coding for human myeloperoxidase. Arch. Biochem. Biophys. 255: 147-155.
52. Yamamoto, K., T. Miyoshi-Koshio, Y. Utsuki, S. Mizuno, and K. Suzuki. 1991. Virucidal activity and viral protein modification by myeloperoxidase: a candidate for defense factor of human polymorphonuclear leukocytes against influenza virus infection. J. Infect. Dis. 164:8-14.
53. Yamamoto, K., K. Suzuki, K. Suzuki, and S. Mizuno. 1989. Phagocytosis and ingestion of influenza virus by human polymorphonuclear leukocytes in vitro. J. Med. Microbiol. 28:91-198.
54. Zaki, S. R., G. E. Austin, W. C. Chan, A. L. Conaty, S. Trusler, S. Trappier, R. B. Lindsey, and D. C. Swan. 1990. Chromosomal localization of the human myeloperoxidase gene by in situ hybridization using oligonucleotide probes. Genes Chromosomes Cancer 2:266-270.
55. Zaki, S. R., G. E. Austin, D. C. Swan, W. C. Hooper, P. W. Greer, B. L. Evatt, and W. C. Chan. 1990. Studies of myeloperoxidase gene expression at the cellular level by in situ hybridization. Leukemia 4:813-818.